(ENTA)—GILD’s COO John Milligan (on 3Q15 CC) said HCV payer contracts for 2016 are already solidified, and hence Milligan sees no effect on payer contracts from the recent V-Pak label change.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”